IntelGenx Technologies Corp. – OTC:IGXT
IntelGenx Technologies Corp. stock price today
IntelGenx Technologies Corp. stock price monthly change
IntelGenx Technologies Corp. stock price quarterly change
IntelGenx Technologies Corp. stock price yearly change
IntelGenx Technologies Corp. key metrics
Market Cap | 38.42M |
Enterprise value | 27.09M |
P/E | -2.43 |
EV/Sales | 17.09 |
EV/EBITDA | -2.12 |
Price/Sales | 14.69 |
Price/Book | -6.80 |
PEG ratio | 0.21 |
EPS | -0.06 |
Revenue | 1.05M |
EBITDA | -10.10M |
Income | -11.03M |
Revenue Q/Q | 7.40% |
Revenue Y/Y | 20.11% |
Profit margin | -1006.94% |
Oper. margin | -434.38% |
Gross margin | -38.11% |
EBIT margin | -434.38% |
EBITDA margin | -961.75% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeIntelGenx Technologies Corp. stock price history
IntelGenx Technologies Corp. stock forecast
IntelGenx Technologies Corp. financial statements
| Jun 2023 | 133K | -2.86M | -2153.38% |
|---|---|---|---|
| Sep 2023 | 318K | -2.75M | -867.61% |
| Dec 2023 | 426K | -1.38M | -323.94% |
| Mar 2024 | 174K | -4.02M | -2314.37% |
| 2025 | 48.44M | 22.70M | 46.86% |
|---|
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 7824000 | 16.97M | 217.01% |
|---|---|---|---|
| Sep 2023 | 8113000 | 19.01M | 234.43% |
| Dec 2023 | 8282000 | 20.52M | 247.87% |
| Mar 2024 | 6548000 | 21.91M | 334.67% |
| Jun 2023 | -2.31M | 552K | -9K |
|---|---|---|---|
| Sep 2023 | -1.42M | 580K | 1.97M |
| Dec 2023 | -441.72K | 100.92K | 1.08M |
| Mar 2024 | -2.85M | 0 | 943K |
IntelGenx Technologies Corp. alternative data
| Aug 2023 | 48 |
|---|---|
| Sep 2023 | 48 |
| Oct 2023 | 48 |
| Nov 2023 | 48 |
| Dec 2023 | 48 |
| Jan 2024 | 48 |
| Feb 2024 | 48 |
| Mar 2024 | 48 |
| Apr 2024 | 48 |
| May 2024 | 48 |
| Jun 2024 | 48 |
| Jul 2024 | 48 |
IntelGenx Technologies Corp. other data
| Period | Buy | Sel |
|---|---|---|
| Sep 2022 | 131500 | 0 |
| Aug 2023 | 11999100 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | ATAI LIFE SCIENCES N.V. 10 percent owner | Warrant (Right to Buy) | 11,999,100 | $0.26 | $3,119,766 | ||
Purchase | ATAI LIFE SCIENCES N.V. 10 percent owner | Convertible Promissory Note | 0 | $0.19 | $0 | ||
Purchase | ZERBE HORST G director, officer.. | Common Stock, 0.00001 p.V | 14,000 | $0.12 | $1,736 | ||
Purchase | ZERBE HORST G director, officer.. | Common Stock, 0.00001 p.V | 5,000 | $0.13 | $640 | ||
Purchase | GODIN ANDRE officer: President and CFO | Common Stock, 0.00001 p.V. | 5,000 | $0.12 | $620 | ||
Purchase | GODIN ANDRE officer: President and CFO | Common Stock, 0.00001 p.V. | 9,000 | $0.14 | $1,215 | ||
Purchase | GODIN ANDRE officer: President and CFO | Common Stock, 0.00001 p.V. | 1,000 | $0.13 | $131 | ||
Purchase | KENNY TOMMY officer: VP IP Legal Affairs-Su.. | Common Stock, 0.00001 p.V. | 19,000 | $0.14 | $2,565 | ||
Purchase | KENNY TOMMY officer: VP IP Legal Affairs-Su.. | Common Stock, 0.00001 p.V | 8,000 | $0.15 | $1,176 | ||
Purchase | KENNY TOMMY officer: VP IP Legal Affairs-Su.. | Common Stock, 0.00001 p.V | 2,000 | $0.15 | $296 |
| Quarter | Transcript |
|---|---|
| Q4 2023 21 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 9 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 14 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Q1 2023 11 May 2023 | Q1 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Dr. Horst G. Zerbe (1947) Chairman, Chief Executive Officer & Chairman of Scientific Advisory Board | $240,750 |
Mr. André Godin C.A., CPA, CPA, CA (1964) Pres & Chief Financial Officer | $223,600 |
| Dr. Dana Matzen (1978) Vice President of Bus. & Corporation Devel. of IntelGenx Corp | $171,430 |
| Ms. Nadine Paiement (1977) Vice-Chair of Scientific Advisory Board and Vice President of R&D - IntelGenx Corp | $140,130 |
-
What's the price of IntelGenx Technologies Corp. stock today?
One share of IntelGenx Technologies Corp. stock can currently be purchased for approximately $0.2.
-
When is IntelGenx Technologies Corp.'s next earnings date?
Unfortunately, IntelGenx Technologies Corp.'s (IGXT) next earnings date is currently unknown.
-
Does IntelGenx Technologies Corp. pay dividends?
No, IntelGenx Technologies Corp. does not pay dividends.
-
How much money does IntelGenx Technologies Corp. make?
IntelGenx Technologies Corp. has a market capitalization of 38.42M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 9.37% to 1.04M US dollars.
-
What is IntelGenx Technologies Corp.'s stock symbol?
IntelGenx Technologies Corp. is traded on the OTC under the ticker symbol "IGXT".
-
What is IntelGenx Technologies Corp.'s primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of IntelGenx Technologies Corp.?
Shares of IntelGenx Technologies Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are IntelGenx Technologies Corp.'s key executives?
IntelGenx Technologies Corp.'s management team includes the following people:
- Dr. Horst G. Zerbe Chairman, Chief Executive Officer & Chairman of Scientific Advisory Board(age: 78, pay: $240,750)
- Mr. André Godin C.A., CPA, CPA, CA Pres & Chief Financial Officer(age: 61, pay: $223,600)
- Dr. Dana Matzen Vice President of Bus. & Corporation Devel. of IntelGenx Corp(age: 47, pay: $171,430)
- Ms. Nadine Paiement Vice-Chair of Scientific Advisory Board and Vice President of R&D - IntelGenx Corp(age: 48, pay: $140,130)
-
How many employees does IntelGenx Technologies Corp. have?
As Jul 2024, IntelGenx Technologies Corp. employs 48 workers.
-
When IntelGenx Technologies Corp. went public?
IntelGenx Technologies Corp. is publicly traded company for more then 18 years since IPO on 16 Jan 2007.
-
What is IntelGenx Technologies Corp.'s official website?
The official website for IntelGenx Technologies Corp. is intelgenx.com.
-
Where are IntelGenx Technologies Corp.'s headquarters?
IntelGenx Technologies Corp. is headquartered at 6420 Rue Abrams, Montreal, QC.
-
How can i contact IntelGenx Technologies Corp.?
IntelGenx Technologies Corp.'s mailing address is 6420 Rue Abrams, Montreal, QC and company can be reached via phone at +51 43 317440.
IntelGenx Technologies Corp. company profile:
IntelGenx Technologies Corp.
intelgenx.comOTC
48
Biotechnology
Healthcare
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, INT0053/2020, and INT0054/2020. The company has licensing, development, and supply agreement with Tilray, Inc.; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.
Montreal, QC H4S 1Y2
CIK: 0001098880
ISIN: US45822R1014
CUSIP: 45822R101
